The clinicopathological roles of alpha-B-crystallin and p53 expression in patients with head and neck squamous cell carcinoma

Pathology

Volumn 40, Issue 5, 2008, Pages 500-504

  Boslooper, Karin ^a   King Yin Lam, Alfred ^a,b   Gao, Jin ^a   Weinstein, Stephen ^a   Johnson, Newell ^a  

^a GRIFFITH UNIVERSITY   (Australia)

^b GRIFFITH UNIVERSITY   (Australia)

Author keywords

Alpha B crystallin; Head and neck; Heat shock protein; p53; Squamous cell carcinoma

Indexed keywords

ALPHA CRYSTALLIN; PROTEIN P53;

ADULT; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR CELL; TUMOR DIFFERENTIATION;

EID: 46749136524     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1080/00313020802198010     Document Type: Article

References (22)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global Cancer Statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
2. Carvalho AL, Nishimoto IN, Califano JA, Kowalski LP. Trends in incidence and prognosis for head and neck cancer the United States: a site-specific analysis of the SEER database. Int J Cancer 2005; 114: 806-16.
3. Chin D, Boyle GM, Theile DR, Parsons PG, Coman WB. Molecular introduction to head and neck cancer (HNSCC) carcinogenesis. Br J Plast Surg 2004; 57: 595-602.
4. Thomas GR, Nadiminti H, Regalado J. Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma. Int J Exp Pathol 2005; 86: 347-63.
5. Bauer JH, Helfand SL. New tricks of an old molecule: lifespan regulation by p53. Aging Cell 2006; 5: 437-40.
6. Greenblatt MS, Bennet WP, Hollstein M, Harris CC. Mutations in the p53 tumour suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994; 54: 4855-78.
7. Geisler SA, Olshan AF, Weissler MC, et al. p16 and p53 protein expression as prognostic indicators of survival and disease recurrence from head and neck cancer. Clin Cancer Res 2002; 8: 3445-53.
8. Schmitt E, Brunet M, Hammann A, Solary E, Garrido C. Small heat shock proteins HSP27 and alpha-B-crystallin: cytoprotective and oncogenic functions. Antioxid Redox Signal 2005; 7: 404-13.
9. Gruvberger-Saal SK, Parsons R. Is the small heat shock protein alpha-B-crystallin an oncogene? J Clin Invest 2006; 116: 30-2.
10. Moyano JV, Evans JR, Chen F, et al. Alpha-B-crystallin is a novel oncoprotein that predicts poor clinical outcome in breast cancer. J Clin Invest 2006; 116: 261-70.
11. Chin D, Boyle GM, Williams RM, et al. alpha-B-crystallin, a new independent marker for poor prognosis in head and neck cancer. Laryngoscope 2005; 115: 1239-42.
12. Kamradt MC, Lu M, Werner ME, et al. The small heat shock protein alpha B-crystallin is a novel inhibitor of TRAIL-induced apoptosis that suppresses the activation of caspase-3. J Biol Chem 2005; 280: 1159-66.
13. Cardesa A, Gale N, Nadal A, Zidar N. Squamous cell carcinoma. In: Barnes L, Eveson JE, Sidransky D, editors. World Health Organization Classification of Tumours. Pathology and Genetics, Head and Neck Tumours. Lyon: IARC Press, 2005; 118-23.
14. Calderwood SK, Khaleque MA, Sawyer DB, Ciocca DR. Heat shock protein: chaperones of tumorigenesis. Trends Biochem Sci 2006; 31: 164-72.
15. Liu S, Li J, Tao Y, Xiao X. Small heat shock protein alphaB-crystallin binds to p53 to sequester its translocation to mitochondria during hydrogen peroxide-induced apoptosis. Biochem Biophys Res Commun 2007; 354: 109-14.
16. Nishioka H, Hiasa Y, Hayashi I, Kitahori Y, Konishi N, Sugimura M. Immunohistochemical detection of p53 oncoprotein in human oral squamous cell carcinomas and leukoplakias: comparison with proliferating cell nuclear antigen staining and correlation with clinicopathological findings. Oncology 1993; 50: 426-9.
17. Carlos de Vicente J, Junquera Gutierrez LM, Zapatero AH, et al. Prognostic significance of p53 expression in oral squamous cell carcinoma without neck node metastases. Head Neck 2004; 26: 22-30.
18. Chelouche-Lev D, Kluger HM, Berger AJ, Rimm DL, Price JE. Alpha B-crystallin as a marker of lymph node involvement in breast cancer. Cancer 2004; 100: 2543-8.
19. Koch WM, Brennan JA, Zahurak M, et al. p53 mutation and locoregional treatment failure in head and neck squamous cell carcinoma. J Natl Cancer Inst 1996; 88: 1580-6.
20. Geisler SA, Olshan AF, Weissler MC, et al. p16 and p53 protein expression as prognostic indicators of survival and disease recurrence from head and neck cancer. Clin Cancer Res 2002; 8: 3445-53.
21. Mineta H, Borg A, Dictor M, Wahlberg P, Akervall J, Wennerberg J. p53 mutation, but not p53 overexpression, correlates with survival in head and neck squamous cell carcinoma. Br J Cancer 1998; 78: 1084-90.
22. Warnakulasuriya S, Jia C, Johnson N, Houghton J. P53 and P-glycoprotein expression are significant prognostic markers in advanced head and neck cancer treated with chemo/radiotherapy. J Pathol 2000; 191: 33-8.